Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Peter A. Thompson is an American entrepreneur and businessperson who founded 7 companies, notably: Silverback Therapeutics, Inc., Edgewise Therapeutics, Inc. and Emergent Product Development Seattle and who has been at the helm of 6 different companies. Currently, Dr. Thompson occupies the position of Chairman for Silverback Therapeutics, Inc. (which he founded in 2016), Chairman of Edgewise Therapeutics, Inc. (which he founded in 2017), Managing Director at Strategicon Partners (which he founded in 2011) and Partner at OrbiMed Advisors Private Equity. Dr. Thompson is also Professor at the University of Washington and on the board of 10 other companies.

In his past career Dr. Thompson held the position of Director at Response Biomedical Corp., Venture Partner at ATP Capital LP, Chairman, President & Chief Executive Officer for Emergent Product Development Seattle (he founded the company in 1999), Chairman at Principia Biopharma, Inc., Chairman & Chief Executive Officer of Newyu, Inc. (he founded the company), Vice President-Research & Technology at BD Biosciences, Systems & Reagents, Inc., Vice President-Research & Technology Development at Becton Dickinson Immunocytometry Systems and Vice President & General Manager-Informatics at Chiron Corp.

Dr. Thompson received an undergraduate degree from Brown University and a doctorate from The Warren Alpert Medical School.


Current positions of Peter A. Thompson 
NameTitle Since
Edgewise Therapeutics, Inc.
(Biotechnology & Medical Research)
Chairman 2017
PMV Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Independent Director 2014
Janux Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2021
Silverback Therapeutics, Inc.
(Biotechnology & Medical Research)
Chairman 2016
Corvus Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Independent Director 2014
Alpine Immune Sciences, Inc.
(Biotechnology & Medical Research)
Independent Director 2016
Decibel Therapeutics, Inc.
(Biotechnology & Medical Research)
Director 2020
Cardioxyl Pharmaceuticals, Inc. Director -
Cleave Therapeutics, Inc. Director 2010
OxOnc Development LP Director -
E-Scape Bio, Inc. Director -
Angel Pharmaceuticals Co., Ltd. Director -
University of Washington Professor 2010
OrbiMed Advisors Private Equity Partner 2013
Strategicon Partners Managing Director 2001


Holdings of Peter A. Thompson 
NameEquities%Valuation
Silverback Therapeutics, Inc. (SBTX)
(Biotechnology & Medical Research)
00.0000%0 USD
Janux Therapeutics, Inc. (JANX)
(Biotechnology & Medical Research)
00.0000%0 USD
Alpine Immune Sciences, Inc. (ALPN)
(Biotechnology & Medical Research)
00.0000%0 USD
Corvus Pharmaceuticals, Inc. (CRVS)
(Biotechnology & Medical Research)
00.0000%0 USD
Decibel Therapeutics, Inc. (DBTX)
(Biotechnology & Medical Research)
00.0000%0 USD


Peter A. Thompson: Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
RE
09/24CATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/24ELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/24BARRY DILLER : Stock Futures Weaken After Evergrande Payment Deadline Passes
DJ
More news


© 2021 People and Ownership :   
Peter A. Thompson : Connections